Tag: Merck
Faro banks $37.3M to put AI agents inside clinical trials
Agentic AI platform for clinical development closes a $37.3M Series B led by Merck's health fund and S32.
Personalized mRNA vaccine clears first phase 3 hurdle in melanoma
Merck and Moderna's personalized mRNA shot slowed melanoma recurrence in the first phase 3 win for a neoantigen therapy.
Merck confirms drug design from Stanford’s 37,000-agent virtual biotech
Stanford's virtual biotech of 37,000 AI agents designed a lung cancer drug that Merck later validated.